TFF Group (OTCMKTS:FRFTF) Stock Price Down 2.8% – Time to Sell?

TFF Group (OTCMKTS:FRFTF)’s stock price fell 2.8% on Wednesday . The company traded as low as C$17.50 and last traded at C$17.50. 1,525 shares changed hands during trading, an increase of 77% from the average session volume of 863 shares. The stock had previously closed at C$18.00.

TFF Group Trading Down 2.8%

The business has a 50-day moving average price of C$20.04 and a two-hundred day moving average price of C$20.46.

TFF Group Company Profile

TFF Group (OTCMKTS:FRFTF) is a clinical-stage specialty pharmaceutical company developing and commercializing medicines based on its proprietary thin-film drug delivery platform. The company’s core technology transforms active pharmaceutical ingredients into solid films that dissolve rapidly in the oral cavity or adhere to mucosal surfaces, enabling precise dosing without water, potential improvements in bioavailability and the opportunity to create novel dosage forms. TFF Group’s platform supports a broad range of molecules, from small-molecule drugs and peptides to vaccines and biologics.

Headquartered in Kansas City, Missouri, with research and manufacturing facilities in Europe, TFF Group applies its thin-film technology across multiple therapeutic areas, including central nervous system disorders, hormone replacement therapy, respiratory diseases and vaccines.